GLP-1 denial appeal generator
A GLP-1 denial appeal starts with the written denial letter and the plan's clinical policy or formulary rule. Most denials cite prior authorization, step therapy, BMI thresholds, or non-formulary status, and you can challenge them with documented BMI, comorbidities, and failed therapies mapped to the plan's own criteria. ERISA employer plans often allow up to 180 days for a first internal appeal under 29 CFR 2560.503-1; Medicare Part D and Medicaid use separate clocks printed on your notice.
Loading generator…
Practical guide
How to appeal a GLP-1 insurance denial
Use the GLP-1 denial appeal generator above to draft your letter from your denial details, then have your prescriber review and sign it.
Who this is for
- Adults denied Wegovy, Zepbound, Saxenda, Ozempic, or Mounjaro for weight or diabetes-related use
- People told to try older weight-loss drugs, diet programs, or metformin first
- Prescribers who need a draft letter to review, edit, and sign
- Members whose PBM denied a formulary exception or prior authorization for a GLP-1
- This is not a coverage guarantee and not medical or legal advice
- Medicare Part D and Medicaid have different clocks and forms than commercial plans
What to do
Step 1: Get the exact denial in writing
Ask for the denial letter, reason code, and the clinical policy or formulary rule used. A verbal “not covered” is not enough to appeal. Note the appeal deadline and whether the decision came from the PBM or the health plan.
Step 2: Match the denial type
Prior auth missing, BMI below plan threshold, comorbidity not documented, step therapy incomplete, and non-formulary are different arguments. Answer the specific reason on the letter instead of writing a generic “I need this drug” request.
Step 3: Document BMI, comorbidities, and prior trials
Include recent height/weight or BMI, diagnoses such as hypertension or type 2 diabetes, dates and outcomes of diet, exercise, and prior medications, plus contraindications if a required step drug is unsafe for you.
Step 4: Cite labeling and plan criteria, not slogans
FDA labeling for anti-obesity GLP-1s generally includes BMI ≥30, or BMI ≥27 with a weight-related condition. Your plan may set a higher bar. Quote the plan policy and show where you meet it, or explain why an exception is medically required.
Step 5: Request peer-to-peer or expedited review when appropriate
If the denial is urgent or clinically complex, ask the prescriber to request a peer-to-peer review with the PBM medical director. For situations where delay could seriously jeopardize health, request expedited review in writing and cite the plan's urgent-review rules.
Step 6: File on time through the right channel
Commercial ERISA plans often allow 180 days for a first internal appeal; many ACA plans use shorter windows printed on the EOB. Pharmacy denials may go through a PBM portal such as CoverMyMeds, Caremark, Express Scripts, or OptumRx. Keep fax confirmations or portal receipts.
Documents to gather
- Denial letter / EOB with reason code
- Prescriber notes and BMI documentation
- Comorbidity list and relevant labs
- Failed or contraindicated prior therapies with dates
- Plan clinical policy or formulary page if you have it
- Signed letter of medical necessity from the prescribing clinician
Use the deadline on your denial notice. Do not assume 180 days. Medicare Part D coverage determinations and Medicaid have separate rules.
Weak vs strong wording
Weak
I need Wegovy because I have tried to lose weight and my insurance should cover FDA-approved drugs.
Stronger
Member meets [plan policy] BMI and comorbidity criteria. Phentermine trial 3/2025–6/2025 stopped for [adverse effect]. Prescriber attests metformin is contraindicated due to [reason]. Request coverage of Wegovy 2.4 mg per labeled indication.
Reviewers look for policy criteria and a therapy history, not a general fairness argument.
Weak
My doctor says I need Zepbound and the plan should approve it.
Stronger
Denial cites step therapy requiring [preferred drug]. Member completed 12-week trial of [drug] with <3% weight loss (chart notes attached). BMI 34.2 with obstructive sleep apnea (ICD-10 attached). Request step-therapy exception and coverage of Zepbound per plan policy section [X].
Step-therapy appeals need documented trial outcomes and the plan policy section cited on the denial.
Weak
Ozempic is the same as Wegovy so please cover it for weight loss.
Stronger
Prescription is for semaglutide 2.4 mg for chronic weight management (ICD-10 E66.x). Denial reason: non-formulary. Request formulary exception because member meets BMI/comorbidity criteria and preferred alternatives are contraindicated or previously failed.
Match the billed indication and denial reason; do not swap drugs or indications without clinical support.
Mistakes to avoid
- Appealing Ozempic for weight loss when the denial is a diabetes prior authorization. Use the indication the prescriber billed.
- Skipping the required step-therapy drug without documenting failure, intolerance, or contraindication
- Missing the PBM vs medical-benefit split. Some GLP-1s are pharmacy benefits and appeals go to the PBM, not the medical-claims address.
- Submitting a patient letter without prescriber chart notes that support BMI, comorbidities, and prior trials
Authoritative sources
- FDA: Wegovy prescribing information
- DOL: ERISA claims procedure (29 CFR 2560.503-1)
- CMS: Medicare Part D coverage determinations
Related AppealFlow pages
- Step therapy exception generator
- Prescription / formulary appeal generator
- Wegovy denial walkthrough
- Ozempic prior auth denial guide
- Aetna appeal guide
FAQs
How do I appeal a Wegovy insurance denial?
Request the written denial and the plan's GLP-1 clinical policy. File an internal appeal or PBM exception that documents your BMI, weight-related comorbidities, and any required step-therapy trials with dates and outcomes. A signed prescriber letter of medical necessity should match the chart.
Why was my GLP-1 denied if it is FDA-approved?
FDA approval means a drug may be marketed for labeled uses. Your plan still applies formulary, prior auth, BMI, and step-therapy rules. Those plan rules can be stricter than the label. Appeal by showing you meet the plan's written criteria or that an exception is medically required.
What is step therapy for weight-loss drugs?
The plan may require a trial of a preferred drug, often an older agent, before covering a GLP-1. An exception is appropriate when the preferred drug was tried and failed, caused harm, is contraindicated, or would be ineffective based on the prescriber's documented rationale.
How long do I have to appeal a GLP-1 denial?
Use the deadline printed on your denial or EOB. Many ERISA employer plans allow up to 180 days for a first internal appeal under 29 CFR 2560.503-1. Medicare Part D and Medicaid use different clocks. Missing the deadline can end your appeal rights for that level.
Does BMI 27 with a comorbidity always get coverage?
No. Many commercial policies use BMI ≥30, a higher BMI, a longer lifestyle-program requirement, or a listed comorbidity set. Read the denial policy. If you meet the label but not the plan, ask for an exception with clinical reasons. Do not claim the plan must follow the label alone.
Should my doctor sign the letter?
A signed letter of medical necessity from the prescriber is the usual supporting document PBMs expect. Generate a draft here, then have the clinician edit facts, add chart details, and sign. Do not submit clinical claims the chart does not support.
Where do I submit a pharmacy GLP-1 appeal?
Often through the PBM such as CVS Caremark, Express Scripts, or OptumRx, or through CoverMyMeds, not only the medical-claims address on the EOB. The denial letter lists the correct channel. Employer plans may also allow a plan-level ERISA appeal.
What if Medicare denied Wegovy?
Original Medicare Part D coverage of anti-obesity drugs has been limited; some plan designs differ by year and product. Follow the Part D coverage determination or exception process on your plan's notice. Do not use commercial ERISA deadlines for Part D.
Generate your GLP-1 appeal letter with the tool above, attach chart notes, and file before the date on your denial letter.
Free draft tool · Review with your clinician · Not legal or medical advice · Disclaimer